Analysis of Optimal Treatment Sequencing of Surufatinib and Somatostatin Analogs in Neuroendocrine Tumors: A Retrospective Cohort Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Clinical Trials Related to Neuroendocrine Tumors
Related studies linked through entity extraction aliases.
CardioNETPOL National Registry of Carcinoid Heart Disease
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Study to Assess the Safety and Effectiveness of Novel Radiopharmaceutical Terbium-161 DOTATATE in Metastatic Neuroendocrine Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Sapu003 in Advanced mTOR-sensitive Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Safety, Tolerability and Preliminary Efficacy of NEUK203-13 in Refractory Neuroendocrine Tumor Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior Treatment
- Status
- RECRUITING
- Phase
- N/A
Prospective Multicenter Real-world Study of Surufatinib in Patients With Advanced Neuroendocrine Neoplasms
- Status
- RECRUITING
- Phase
- PHASE4
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
- Status
- RECRUITING
- Phase
- PHASE1
The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers (Guarana Fatigue)
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
18F-AlF-NOTA-Octreotide PET in Neuroendocrine Neoplasms
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Correlation Between Body Composition and Pathologic Grade/Prognosis in GEP-NENs: A Retrospective Study
- Status
- COMPLETED
- Phase
- N/A
18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis
- Status
- RECRUITING
- Phase
- N/A
Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors
- Status
- RECRUITING
- Phase
- NA
SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET)
- Status
- RECRUITING
- Phase
- PHASE1
Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with Long-acting Somatostatin Analogues - ATSA Trial
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
- Status
- RECRUITING
- Phase
- PHASE1
Phase II Study of Adebrelimab, Chemotherapy, and Apatinib for Advanced Pulmonary Neuroendocrine Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, BTC or NEN
- Status
- RECRUITING
- Phase
- NA
Agnostic Therapy in Rare Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2